Matching-adjusted Indirect Comparison of Dermatology Life Quality Index 0/1 Response in Trials of Calcipotriol Plus Betamethasone Dipropionate Foam and Cream Formulations in Patients with Psoriasis.

"Conflicts of interest AJ has been a consultant and advisor and/or received speaking fees and/or grants and/or served as an investigator in clinical trials for the following companies: AbbVie, Almirall, Amgen, Boehringer Ingelheim, BMS, Celgene, Eli Lilly, Galderma, GSK, LEO Pharma, Janssen, MSD, Novartis, Sanofi and UCB. HT and MYJB are employees at LEO Pharma. KAP has received honoraria for advisory board, speaker, consultant services, scientific officer and/or steering committees from AbbVie, Akros, Amgen, Bausch Health/Valeant, Boehringer Ingelheim, Celgene, Celltrion, Coherus, Eli Lilly, Forbion, Galderma, Janssen, Kyowa Hakko Kirin, LEO Pharma, Meiji Seika Pharma, Merck (MSD), Merck-Serono, Mitsubishi Pharma, Novartis, Pfizer, Reistone, Sanofi-Aventis/Genzyme, Sandoz, Takeda, UCB, vTv Therapeutics and Xencor; and has received research grants from AbbVie, Akros, Amgen, Anacor, Arcutis, Astellas, Avillion, Bausch Health/Valeant, Baxalta, Boehringer Ingelheim, Bristol-Myers Squibb, Can-Fite Biopharma, Celgene, Coherus, Dermavant, Dermira, Dow Pharma, Eli Lilly, Evelo, Galapagos, Galderma, Genentech, Gilead, GSK, Incyte, Janssen, Kyowa Hakko Kirin, LEO Pharma, Medimmune, Merck (MSD), Merck- Serono, Moberg Pharma, Novartis, Pfizer, PRCL Research, Regeneron, Roche, Sanofi-Aventis/Genzyme, Sun Pharma, Takeda and UCB."

"Medical writing support, including assisting authors with the development of the manuscript drafts and incorporation of comments, was provided by Juliel Espinosa, PhD of Alphabet Health (New York, NY), supported by LEO Pharma A/S, according to Good Publication Practice guidelines (https://www.ismpp.org/gpp-2022). The authors received no honoraria related to the development of this publication."